Tirzepatide Maintenance Dose: What Happens After Goal Weight

FormBlends Editorial Research. Last reviewed September 9, 2026 against the Zepbound and Mounjaro prescribing information and the trial publications listed under Sources.

The Zepbound label names 5, 10 and 15 mg as maintenance doses, and it does not describe a separate, lower "after goal weight" dose. The one trial that tested what happens next is SURMOUNT-4. Adults who kept taking tirzepatide after 36 weeks lost a further 5.5% over the next year. Those switched to placebo regained 14.0%. What you do after reaching your goal is a decision for you and your prescriber. If you are new to the drug, start with our tirzepatide guide.

Key takeaways

• Maintenance doses on the Zepbound label: 5, 10 or 15 mg once weekly. The 2.5 mg dose is a starting dose only. The maximum is 15 mg.
• SURMOUNT-4: after 36 weeks on tirzepatide (mean loss 20.9%), continuing led to a further 5.5% loss over 52 weeks; switching to placebo led to a 14.0% regain.
• No trial in the Sources tested stepping down to a lower dose or a longer interval after goal weight. The label does not describe either.
• The label sets no maximum duration. The longest trial ran 176 weeks with continued benefit.
• At FormBlends the price is the same at every dose, so a maintenance dose does not change the monthly cost.

What "maintenance dose" means on the tirzepatide label

The label uses "maintenance" to mean the dose you settle on after escalation, not a dose for after you have lost the weight. Everyone starts at 2.5 mg for four weeks, then increases in 2.5 mg steps with at least four weeks on each. The label names three doses as maintenance doses and treats 7.5 and 12.5 mg as steps in between.

Source: Zepbound prescribing information; SURMOUNT-1, Jastreboff et al., NEJM 2022. Placebo lost 3.1%.

So "what is my tirzepatide maintenance dose" has a label answer: whichever of 5, 10 or 15 mg you and your prescriber landed on. The full schedule is on Zepbound doses.

What happens after goal weight: the SURMOUNT-4 evidence

SURMOUNT-4 is the only trial in our sources built to answer this. Adults with obesity took tirzepatide for 36 weeks, escalating to 10 or 15 mg, and lost a mean of 20.9%. They were then randomized to keep taking tirzepatide or to switch to placebo for another 52 weeks. Both groups kept getting lifestyle counseling.

Source: SURMOUNT-4, Aronne et al., JAMA 2024. The "net" column is arithmetic combining the 36-week and 52-week figures and is approximate.

Two lessons. First, staying on the drug kept the weight off and then some. Second, stopping, even with counseling, returned most of the loss within a year. Nothing in the trial says stopping is wrong; it says stopping has a predictable cost. What happens week by week after the last dose is on what happens when you stop taking tirzepatide.

Your options after goal weight, and what the evidence says about each

Source: Zepbound prescribing information; SURMOUNT-4.

Stepping down is the option most people want and the one with the least evidence. Some prescribers do it. If yours does, it is an individual clinical judgment, and the honest thing to say is that no trial in our sources tells you how much weight a lower dose will hold. Plan regular weigh-ins and a threshold for revisiting the dose, and agree on it before you change anything.

How to maintain weight loss after tirzepatide, on or off the drug

Every tirzepatide trial paired the drug with a reduced-calorie diet and increased physical activity, and the label's indication is as an adjunct to both. SURMOUNT-3 shows the relationship from the other direction: after a 12-week intensive lifestyle program, adding tirzepatide produced a further 18.4% loss while placebo gained 2.5%. Lifestyle work is the floor, and the drug builds on it. Off the drug, the SURMOUNT-4 placebo arm shows that counseling alone did not prevent regain, so if you stop, agree with your prescriber on when a restart would be considered. A restart follows the label's escalation from 2.5 mg. Practical habits are collected in the tirzepatide diet plan and how to keep weight off after Zepbound.

How long can you stay on a maintenance dose?

The label sets no limit. Zepbound is approved for chronic weight management, which is a long-term indication by definition. The SURMOUNT-1 three-year extension followed adults with obesity and prediabetes for 176 weeks: weight change was -22.9% at 15 mg versus -2.1% on placebo, and progression to type 2 diabetes fell by 94% (1.3% versus 13.3%). The label's boxed warning and other warnings apply for as long as you take the drug, so ongoing follow-up with your prescriber is part of maintenance.

What this means for compounded tirzepatide

Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate. The maintenance question is the same, with one practical difference: cost. Brand vial prices rise with dose, from $299 a month at 2.5 mg to $699 at 10 mg and above through LillyDirect. At FormBlends, compounded tirzepatide is $149 for the first month, then $239 a month, or $214 a month with Subscribe & Save, and the price is the same at 5, 10 or 15 mg. Longer plans are one-time charges: 3 months $627, 6 months $1,194, 12 months $2,148. See pricing or begin at start.

Frequently Asked Questions

What is the tirzepatide maintenance dose after weight loss?

The label's maintenance doses are 5, 10 and 15 mg once weekly, and it does not define a separate dose for after you reach your goal. Most people stay on the dose that got them there. Any change is a prescriber decision.

How do I maintain weight loss after tirzepatide?

The only trial-tested strategy is continuing the drug: SURMOUNT-4 showed a further 5.5% loss over 52 weeks versus a 14.0% regain on placebo. Diet and activity are part of the label's indication and remain essential either way.

Can I drop to a lower dose once I hit goal weight?

No trial in our sources tested it and the label does not describe it. Some prescribers do it as an individual decision. If yours agrees, set a weigh-in schedule and a threshold for revisiting the dose in advance.

What is tirzepatide maintenance?

On the label it means the dose you stay on after escalation: 5, 10 or 15 mg. In everyday use it also means the phase after weight loss when the goal is holding steady rather than losing more.

How long should I stay on a maintenance dose?

The label sets no maximum, and the longest trial ran 176 weeks with continued benefit. Duration depends on your goals, side effects, cost and your prescriber's judgment.

Sources

1. Zepbound (tirzepatide) prescribing information, Eli Lilly via DailyMed, revised 08/2026.
2. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4), Aronne et al., JAMA, 2024.
3. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), Jastreboff et al., New England Journal of Medicine, 2022.
4. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3), Wadden et al., Nature Medicine, 2023.
5. Tirzepatide for Obesity Treatment and Diabetes Prevention (SURMOUNT-1 3-year), Jastreboff et al., New England Journal of Medicine, 2025.
6. FormBlends pricing, Form Blends LLC, verified September 5, 2026.

Next steps

Read what happens when you stop taking tirzepatide and how to keep weight off after Zepbound. Browse the tirzepatide hub for every other tirzepatide question. Talk to a clinician before changing your dose or stopping. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.